Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from FibroBiologics, Inc. ( (FBLG) ).
On March 25, 2026, FibroBiologics, Inc. filed a Certificate of Amendment in Delaware, which took effect on March 30, 2026, to implement a one-for-twenty reverse stock split of its issued and outstanding common shares. The reverse split changed the CUSIP number, left the FBLG trading symbol unchanged, and converted every 20 shares into one share while rounding any fractional shares up to the nearest whole share.
The transaction uniformly affected all stockholders and was structured not to change any investor’s percentage ownership interest in the company, aside from minor adjustments for fractional shares. It also proportionately adjusted the shares available under the company’s equity incentive plan, as well as the exercise price and share count of outstanding stock options and warrants, without altering the par value or authorized number of common shares.
The most recent analyst rating on (FBLG) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on FibroBiologics, Inc. stock, see the FBLG Stock Forecast page.
Spark’s Take on FBLG Stock
According to Spark, TipRanks’ AI Analyst, FBLG is a Underperform.
The score is primarily weighed down by weak financial performance (no revenue, widening losses, and increasing cash burn) and very bearish technical signals (price far below key moving averages with extremely low RSI/Stoch). Corporate events add meaningful risk due to Nasdaq delisting uncertainty and potential reverse split dynamics, while valuation provides limited support given negative earnings and no dividend.
To see Spark’s full report on FBLG stock, click here.
More about FibroBiologics, Inc.
FibroBiologics, Inc. is a publicly traded company whose common stock is listed under the ticker symbol FBLG. The company’s capital structure includes common stock with a par value of $0.00001 per share, and it maintains an equity incentive plan with stock options and warrants outstanding for employees and other stakeholders.
Average Trading Volume: 298,155
Technical Sentiment Signal: Sell
Current Market Cap: $4.85M
See more insights into FBLG stock on TipRanks’ Stock Analysis page.